They found that PTs with fibroadenoma-like areas were more likely to harbor mutations in exon 2 of MED12, a gene often altered in benign breast fibroepithelial tumors, whereas PTs without fibroadenoma-like areas more commonly had mutations in EGFR and other known cancer genes. Here, MED12 is linked to cancer.